ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P 500
5,537.02
0.51%
US Tech 100
19,641.60
0.83%
Dow Jones
39,308.00
-0.06%
Brent Oil
86.97
0.07%
Bitcoin
56,949.40
-5.34%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Chemomab Therapeutics Ltd (CMMB)

  7. Chemomab Therapeutics Ltd (CMMB) News

CMMB

Chemomab Therapeutics (CMMB)

Chemomab Therapeutics Ltd
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:CMMB
DateTimeSourceHeadlineSymbolCompany
11/06/202312:15AMEdgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:CMMBChemomab Therapeutics Ltd
10/30/20238:33AMEdgar (US Regulatory)Form F-3/A - Registration statement by foreign private issuers: [Amend]NASDAQ:CMMBChemomab Therapeutics Ltd
10/30/20237:00AMPR Newswire (US)Chemomab Therapeutics to Report Third Quarter 2023 Financial Results and Provide a Business UpdateNASDAQ:CMMBChemomab Therapeutics Ltd
10/26/20237:00AMPR Newswire (US)Chemomab Therapeutics to Present at Upcoming Scientific ConferencesNASDAQ:CMMBChemomab Therapeutics Ltd
10/16/20234:25PMEdgar (US Regulatory)Form F-3 - Registration statement by foreign private issuersNASDAQ:CMMBChemomab Therapeutics Ltd
09/28/20237:00AMPR Newswire (US)Chemomab Therapeutics to Present Its CM-101 Clinical Program in Primary Sclerosing Cholangitis at 2023 Roth MKM Healthcare Opportunities ConferenceNASDAQ:CMMBChemomab Therapeutics Ltd
08/29/20237:00AMPR Newswire (US)Chemomab Therapeutics to Present at the H.C. Wainwright 25th Annual Global Investment ConferenceNASDAQ:CMMBChemomab Therapeutics Ltd
08/14/20238:05AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:CMMBChemomab Therapeutics Ltd
08/14/20238:00AMPR Newswire (US)Chemomab Therapeutics Announces Second Quarter 2023 Financial Results and Provides a Corporate UpdateNASDAQ:CMMBChemomab Therapeutics Ltd
08/08/20236:00AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:CMMBChemomab Therapeutics Ltd
07/05/20235:48PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CMMBChemomab Therapeutics Ltd
07/03/20233:49PMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:CMMBChemomab Therapeutics Ltd
06/28/20237:00AMPR Newswire (US)Chemomab Therapeutics Announces Publication in JCI Insight Demonstrating Key Role of CCL24 in Primary Sclerosing CholangitisNASDAQ:CMMBChemomab Therapeutics Ltd
06/26/20237:00AMPR Newswire (US)Chemomab Therapeutics Presents Data Reinforcing the Clinical Potential of CM-101 as a Novel Treatment for Primary Sclerosing Cholangitis at EASL 2023NASDAQ:CMMBChemomab Therapeutics Ltd
06/21/20237:00AMPR Newswire (US)Chemomab Therapeutics Reports Positive Data from Secondary Analysis of Phase 2a Liver Fibrosis Trial in NASH Patients at EASL 2023NASDAQ:CMMBChemomab Therapeutics Ltd
06/16/20234:02PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CMMBChemomab Therapeutics Ltd
06/05/20237:01AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CMMBChemomab Therapeutics Ltd
06/05/20237:00AMPR Newswire (US)Chemomab Therapeutics Announces Executive Leadership Changes and Provides a Corporate UpdateNASDAQ:CMMBChemomab Therapeutics Ltd
06/02/20239:00AMPR Newswire (US)Patient Data Presented at 2023 EULAR Congress Highlights How Serum CCL24 Levels Can Predict Vascular and Fibrotic Complications of Systemic SclerosisNASDAQ:CMMBChemomab Therapeutics Ltd
05/24/20237:00AMPR Newswire (US)Chemomab Therapeutics to Participate in Upcoming Scientific ConferencesNASDAQ:CMMBChemomab Therapeutics Ltd
05/19/20234:07PMEdgar (US Regulatory)Securities Registration Statement (s-1/a)NASDAQ:CMMBChemomab Therapeutics Ltd
05/11/20236:08AMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:CMMBChemomab Therapeutics Ltd
05/11/20236:00AMPR Newswire (US)Chemomab Therapeutics Announces First Quarter 2023 Financial Results and Provides a Corporate UpdateNASDAQ:CMMBChemomab Therapeutics Ltd
04/26/20237:00AMPR Newswire (US)Chemomab Therapeutics to Present at 2023 Aegis Virtual ConferenceNASDAQ:CMMBChemomab Therapeutics Ltd
04/19/20237:00AMPR Newswire (US)Chemomab Therapeutics to Present at Upcoming Scientific ConferencesNASDAQ:CMMBChemomab Therapeutics Ltd
04/12/20237:00AMPR Newswire (US)Chemomab Therapeutics to Discuss First Quarter 2023 Financial Results and Provide a Corporate UpdateNASDAQ:CMMBChemomab Therapeutics Ltd
03/29/20238:30AMPR Newswire (US)Chemomab Therapeutics to Provide a Corporate Update on April 17, 2023NASDAQ:CMMBChemomab Therapeutics Ltd
03/23/20237:37AMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CMMBChemomab Therapeutics Ltd
03/23/20237:36AMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CMMBChemomab Therapeutics Ltd
03/23/20237:34AMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CMMBChemomab Therapeutics Ltd
 Showing the most relevant articles for your search:NASDAQ:CMMB

Your Recent History

USOTC
CNNA
Cann American (CE)
USOTC
SPZI
Spooz (PK)
NASDAQ
TSLA
Tesla
USOTC
NSAV
Net Savings Link (PK)
USOTC
KEGS
1812 Brewing (PK)
USOTC
SFRX
Seafarer Exploration (PK)
USOTC
NLST
Netlist (QB)
COIN
BTCUSD
Bitcoin
USOTC
MGON
Megola (PK)
USOTC
VPLM
Voip Pal Com (QB)
USOTC
BLEG
Branded Legacy (PK)
USOTC
UBQU
Ubiquitech Software (PK)
USOTC
VXIT
Virexit Technologies (PK)
USOTC
ENZC
Enzolytics (PK)
NASDAQ
CDMO
Avid Bioservices
USOTC
RXMD
Progressive Care (QB)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved